Incretin-based drugs and the kidney in type 2 diabetes: choosing between DPP-4 inhibitors and GLP-1 receptor agonists

Mann J, Muskiet MHA (2021)

Publication Type: Journal article, Editorial

Publication year: 2021

Journal

Kidney International Nature Publishing Group: Open Access Hybrid Model Option A

Book Volume: 99

Pages Range: 314-318

Journal Issue: 2

DOI: 10.1016/j.kint.2020.08.036

Involved external institutions

Vrije Universiteit Amsterdam (VU) / University Amsterdam NL Netherlands (NL)

How to cite

APA:

Mann, J., & Muskiet, M.H.A. (2021). Incretin-based drugs and the kidney in type 2 diabetes: choosing between DPP-4 inhibitors and GLP-1 receptor agonists. Kidney International, 99(2), 314-318. https://doi.org/10.1016/j.kint.2020.08.036

MLA:

Mann, Johannes, and Marcel H. A. Muskiet. "Incretin-based drugs and the kidney in type 2 diabetes: choosing between DPP-4 inhibitors and GLP-1 receptor agonists." Kidney International 99.2 (2021): 314-318.

BibTeX: Download